Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents

• Asıl Yazarlar: Daniel A. Ladin (Yazar), Eman Soliman (Yazar), LaToya Griffin (Yazar), Rukiyah Van Dross-Anderson (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2016-10-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Cancer is the second leading cause of death in the United States with 1.7 million new cases estimated to be diagnosed in 2016. This disease remains a formidable clinical challenge and represents a substantial financial burden to the US health care system. Therefore, research and development of novel...